DCBO Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

61.70M

+8.17%

0.388

+38.39%

62.15M

+8.48%

0.333

+23.46%

64.22M

+5.74%

0.370

+27.59%

Estimates Revision

The market is revising Upward the revenue expectations for Docebo Inc. (DCBO) for FY2025, with the revenue forecasts being adjusted by 0.7% over the past three months. During the same period, the stock price has changed by -20.29%.

Revenue Estimates for FY2025

Revise Upward

+0.7%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+11.08%

In Past 3 Month

Stock Price

Go Down

-20.29%

In Past 3 Month

7 Analyst Rating

Wall Street analysts forecast DCBO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DCBO is 35.43 USD with a low forecast of 28.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

28.00

Averages

35.43

High

40.00

Current: 0.000

Low

28.00

Averages

35.43

High

40.00

Cantor Fitzgerald

initiated

$35

2025-12-24

Reason

Cantor Fitzgerald

Price Target

$35

2025-12-24

initiated

Reason

Cantor Fitzgerald assumed coverage of Docebo with an Overweight rating and $35 price target. The firm is updating research coverage in the Security & Infrastructure Software sector due to analyst departure and reallocation of analyst resources.

ATB Capital

Sector Perform -> Outperform

upgrade

$50

2025-12-10

Reason

ATB Capital

Price Target

$50

2025-12-10

upgrade

Sector Perform -> Outperform

Reason

ATB Capital upgraded Docebo to Outperform from Sector Perform with a C$50 price target.

Morgan Stanley

Equal Weight

downgrade

$34 -> $28

2025-11-10

Reason

Morgan Stanley

Price Target

$34 -> $28

2025-11-10

downgrade

Equal Weight

Reason

Morgan Stanley lowered the firm's price target on Docebo to $28 from $34 and keeps an Equal Weight rating on the shares.

Oppenheimer

Outperform

initiated

$35

2025-11-05

Reason

Oppenheimer

Price Target

$35

2025-11-05

initiated

Outperform

Reason

Oppenheimer initiated coverage of Docebo with an Outperform rating and $35 price target. The company is a leading provider of learning management systems and its growth has outpaced the market by displacing legacy vendors, moving upmarket, and extending into new markets, the analyst tells investors in a research note. The firm sees Docebo's average revenue per user as a key growth driver with management prioritizing enterprise sales.

CIBC

Outperformer

maintain

$37 -> $36

2025-10-29

Reason

CIBC

Price Target

$37 -> $36

2025-10-29

maintain

Outperformer

Reason

CIBC lowered the firm's price target on Docebo to $36 from $37 and keeps an Outperformer rating on the shares. The firm notes that software stocks under coverage were down an average of 8% in Q3, significantly underperforming the TSX amid concerns over AI disruptions and company-specific factors. Estimate revisions continued post Q2, with the Street lowering 2025 EBITDA estimates for the companies in our coverage by an average of 7%. CIBC expects another volatile earnings season with Q3 results and expects that earnings misses will see outsized market reactions.

Canaccord

Buy

maintain

$43 -> $46

2025-08-11

Reason

Canaccord

Price Target

$43 -> $46

2025-08-11

maintain

Buy

Reason

Canaccord raised the firm's price target on Docebo to $46 from $43 and keeps a Buy rating on the shares. The firm said they reported an excellent quarter with better-than-expected Q2 results and Q3 guidance. With more confidence on the macro after tariff induced uncertainty, albeit still with caution amid longer sales cycles and deal scrutiny, management also bumped its full year guidance.

Valuation Metrics

The current forward P/E ratio for Docebo Inc (DCBO.O) is 15.95, compared to its 5-year average forward P/E of -215.86. For a more detailed relative valuation and DCF analysis to assess Docebo Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-215.86

Current PE

15.95

Overvalued PE

424.18

Undervalued PE

-855.91

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

121.56

Current EV/EBITDA

11.73

Overvalued EV/EBITDA

982.65

Undervalued EV/EBITDA

-739.54

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

8.15

Current PS

2.54

Overvalued PS

13.09

Undervalued PS

3.21

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areBuying! The buying amount has increased 1100% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

DCBO News & Events

Events Timeline

No data

News

5.0

2025-12-10Yahoo Finance

HEALWELL AI Names Ian Kidson as New Board Member

8.5

2025-11-28NASDAQ.COM

Intercap Equity Set to Purchase Stake in Docebo for About $68.1 Million

6.0

2025-11-10Benzinga

Morgan Stanley Keeps Equal-Weight Rating on Docebo, Reduces Price Target to $28

People Also Watch

Frequently Asked Questions

What is Docebo Inc (DCBO) stock price today?

The current price of DCBO is 21.88 USD — it has decreased -0.59 % in the last trading day.

What is Docebo Inc (DCBO)'s business?

Docebo Inc. is a provider of learning platforms with a foundation in artificial intelligence (AI) and innovation. The Company is redefining the way enterprises leverage technology to create and manage content, deliver training, and measure the business impact of their learning programs. Its learning platform includes capabilities, such as learning management and delivery, content marketplace, insights, learning evaluation, advanced analytics, communities, ecommerce, integrations, headless learning, and AI authoring. Its end-to-end learning platform, organizations worldwide are equipped to deliver scaled, personalized learning across all their audiences and use cases, driving growth and powering their business. Its learning platform leverages artificial intelligence and a high-performance workflow engine to save time, handle repetitive tasks, and automate processes. It serves small and medium-sized businesses to large globally distributed enterprises in a wide variety of industries.

What is the price predicton of DCBO Stock?

What is Docebo Inc (DCBO)'s revenue for the last quarter?

Docebo Inc revenue for the last quarter amounts to 61.62M USD, increased 11.16 % YoY.

What is Docebo Inc (DCBO)'s earnings per share (EPS) for the last quarter?

Docebo Inc. EPS for the last quarter amounts to 0.21 USD, increased 31.25 % YoY.

What changes have occurred in the market's expectations for Docebo Inc (DCBO)'s fundamentals?

How many employees does Docebo Inc (DCBO). have?

Docebo Inc (DCBO) has 900 emplpoyees as of January 10 2026.

What is Docebo Inc (DCBO) market cap?

Today DCBO has the market capitalization of 628.72M USD.